M-H Horellou - JoVE Visualize

Showing results (51-60 of 97) with videos related to

Pageof 10

Sort By:

Blood|March 15, 1994

Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand diseaseL Hilbert, C Gaucher, C de Romeuf, et al.

American Journal of Clinical Pathology|October 1, 1995

Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.

Presse Medicale (Paris, France : 1983)|January 28, 1995

[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.

Annales Pharmaceutiques Francaises|November 16, 2010

[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems]M Samama, J Conard, M-H Horellou, et al.

Bulletin De L'Academie Nationale De Medecine|May 1, 1997

[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.

Thrombosis Research|February 18, 2014

Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French studyL Maitrot-Mantelet, M H Horellou, H Massiou, et al.

La Nouvelle Presse Medicale|April 11, 1981

[Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl)]J Conard, E Terrier, M Baillet, et al.

Journal Des Maladies Vasculaires|January 1, 1988

[Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports]J Conard, M H Horellou, B Wechsler, et al.

La Nouvelle Presse Medicale|December 17, 1977

[The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)]J Soria, C Soria, S de Rodriguez, et al.

Seminars in Vascular Medicine|November 23, 2005

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implicationsM M Samama, M H Horellou, I Elalamy, et al.

Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:

Pageof 10

Blood|March 15, 1994

Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand diseaseL Hilbert, C Gaucher, C de Romeuf, et al.

American Journal of Clinical Pathology|October 1, 1995

Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.

Presse Medicale (Paris, France : 1983)|January 28, 1995

[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.

Annales Pharmaceutiques Francaises|November 16, 2010

[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems]M Samama, J Conard, M-H Horellou, et al.

Bulletin De L'Academie Nationale De Medecine|May 1, 1997

[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.

Thrombosis Research|February 18, 2014

Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French studyL Maitrot-Mantelet, M H Horellou, H Massiou, et al.

La Nouvelle Presse Medicale|April 11, 1981

[Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl)]J Conard, E Terrier, M Baillet, et al.

Journal Des Maladies Vasculaires|January 1, 1988

[Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports]J Conard, M H Horellou, B Wechsler, et al.

La Nouvelle Presse Medicale|December 17, 1977

[The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)]J Soria, C Soria, S de Rodriguez, et al.

Seminars in Vascular Medicine|November 23, 2005

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implicationsM M Samama, M H Horellou, I Elalamy, et al.

Pageof 10